Pfizer Inc has applied for approval from Japan's health ministry to use COVID-19 vaccines on children aged 5 to 11, it said in a statement released on Wednesday.
Pfizer's Comirnaty vaccine, developed in partnership with BioNTech, was the first COVID-19 vaccine approved for Japan's general public in February. COVID-19 vaccines developed by Moderna and AstraZeneca have since been approved.
Pfizer's vaccine is currently being offered to those aged 12 and above. If approved by the health ministry, it will be the first to be administered to children under 11 in Japan.
About 74 per cent of the population is now fully vaccinated, according to broadcaster NHK, and the government is widely expected to start administering booster shots by year-end.
India caps airline fares as IndiGo crisis leaves hundreds stranded for fifth day
Pakistan, Afghanistan border clashes kill 5, officials say
Gaza talks at critical moment, ceasefire not complete, Qatar's PM says
Indonesians climb over logs in walk to aid centre as flood deaths rise over 900
Russian drones, missiles hit railway hub near Ukraine's capital
